Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of a Single Intra-articular Injection of Ampion in Adults With Pain Due to Osteoarthritis (OA) of the Knee

Next Previous
X
Search
Trial Profile

A Phase 3 Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of a Single Intra-articular Injection of Ampion in Adults With Pain Due to Osteoarthritis (OA) of the Knee

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 12 Aug 2022

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs DMI 9523 (Primary)
  • Indications Musculoskeletal pain; Osteoarthritis
  • Focus Registrational; Therapeutic Use
  • Acronyms STEP
  • Sponsors Ampio Pharmaceuticals

    • Most Recent Events

    • 17 Jun 2021 According to an Ampio Pharmaceuticals media release, pooled results from AP-003-A, AP-003-B, and AP-004 trials had been published in Orthopedics 2018.
    • 17 Jun 2021 Pooled results from AP-003-A, AP-003-B, and AP-004 trials presented in an Ampio Pharmaceuticals media release.
    • 22 Nov 2017 Pooled analysis of this and 2 other trials (see CT profiles 214957 and 261154) has been published in Orthopedics, according to an Ampio Pharmaceuticals media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top